LAKE FOREST, Ill., June 11, 2012 /PRNewswire/ -- Hospira (NYSE:
HSP), the world's leading provider of injectable drugs and infusion
technologies, today released an important enhancement to its
TheraDoc™ clinical surveillance system designed to support hospital
antimicrobial stewardship efforts, with the goal of helping to
improve patient outcomes, reduce antimicrobial resistant infections
and reduce costs. The new TheraDoc system version 4.5, which
further automates the monitoring and reporting of infections and
antibiotic use, includes powerful features that can assist
pharmacists and infection preventionists in maximizing the benefits
of clinical surveillance throughout their organizations.
(Logo:
http://photos.prnewswire.com/prnh/20040503/HSPLOGO)
Improving antibiotic use is a key priority for hospitals
nationwide, and antimicrobial stewardship plays a critical role in
fighting antimicrobial resistance by ensuring appropriate drug
selection, dosing and duration. According to the Centers for
Disease Control and Prevention (CDC), studies indicate that nearly
50 percent of antimicrobial use in hospitals is unnecessary or
inappropriate, and that the overuse of antibiotics is contributing
to the growing challenges posed by Clostridium difficile and
other antibiotic-resistant bacteria.[1]
"The upgraded TheraDoc system helps hospitals leverage patient
data to improve antibiotic use, combat antimicrobial resistance,
and ultimately save lives," said France
Pitera, vice president, Clinical Information Technology,
Hospira. "The software upgrade also helps hospitals improve
antimicrobial utilization reporting -- a result of TheraDoc's early
work with the CDC on its Antimicrobial Usage Reporting project. We
are committed to being at the forefront of clinical surveillance
and reporting, as integrating and exchanging relevant patient
information supports efforts to protect patients and improve
healthcare quality."
The TheraDoc system version 4.5 features a new electronic
medication administration record (eMAR) interface that integrates
medical administration records into the TheraDoc system, allowing
hospitals to monitor antimicrobial utilization using days of
therapy or defined daily dose and export this data to the NHSN. The
eMAR interface also helps infection preventionists improve patient
care by simplifying the process of isolation management.
Other upgrades include an antimicrobial usage dashboard that
displays medication administration data, and antimicrobial alerts
that help clinicians monitor duration of therapy, identify
de-escalation opportunities, and recognize redundant or duplicate
therapies, potentially saving money on antimicrobial drugs.
Upgraded NHSN definitions are designed to increase the efficiency
and accuracy of NHSN reporting.
This upgrade helps hospitals expand their use of TheraDoc
technology, which has shown many benefits for hospitals over more
than 10 years. Lori McSorley, an
infection preventionist at St. Luke's Hospital, Warren Campus, in New
Jersey, said using the TheraDoc system helps significantly
reduce the time it takes for NHSN data collection and
reporting.
"Before TheraDoc, it would take 10-15 minutes per patient to
collect and review surgical site infection data before in putting
it into the NHSN system," she said. "Now, information on all of our
surgeries, including the start and stop time, class of surgery, and
patient ASA [physical status] score, can be obtained automatically
through the TheraDoc system. I just click on a surgery, and the
data are immediately available for review and exporting to NHSN. I
can report information on 10 patients in the time it took me to
report one using manual methods."
The new TheraDoc system version 4.5 is being demonstrated at the
American Society of Health-System Pharmacists (ASHP) Summer Meeting
and Exhibition in Baltimore,
through June 12 (Booth
#910).
Hospira's TheraDoc Clinical Surveillance System
Hospira's TheraDoc clinical surveillance system has been
chosen by more than 440 U.S. hospitals and healthcare facilities,
making critical patient information and medical knowledge readily
available to help clinicians intervene quickly, prescribe
appropriately, and improve the quality of patient care. The
TheraDoc Clinical Intelligence™ Platform is the engine that powers
several knowledge modules, including the Infection Control
Assistant™, Antibiotic Assistant™, ADE Assistant™, Clinical Alerts
Assistant™ and Anticoagulation Assistant™. For more information,
visit www.theradoc.com or call (801) 415-4400.
About Hospira
Hospira, Inc., is the world's leading provider of
injectable drugs and infusion technologies. Through its broad,
integrated portfolio, Hospira is uniquely positioned to Advance
Wellness™ by improving patient and caregiver safety while reducing
healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately
15,000 employees. Learn more at www.hospira.com.
Private Securities Litigation Reform Act of 1995 --
A Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995, including statements regarding the enhanced TheraDoc
system. Hospira cautions that these forward-looking statements are
subject to risks and uncertainties that may cause actual results to
differ materially from those indicated in the forward-looking
statements. Economic, competitive, governmental, regulatory,
quality, legal, technological and other factors that may affect
Hospira's operations and may cause actual results to be materially
different from expectations include the risks, uncertainties and
factors discussed under the headings "Risk Factors" and
"Management's Discussion and Analysis of Financial Condition and
Results of Operations" in Hospira's latest Annual Report on Form
10-K and Form 10-Q filed with the Securities and Exchange
Commission, which are incorporated by reference. Hospira undertakes
no obligation to release publicly any revisions to forward-looking
statements as the result of subsequent events or
developments.
[1] Centers for Disease Control and Prevention. Get Smart for
Healthcare. 2011. http://www.cdc.gov/getsmart/healthcare/. Accessed
May 22, 2012.
SOURCE Hospira, Inc.